Qin, Xunsi http://orcid.org/0000-0002-5869-8873
Zhao, Yue http://orcid.org/0000-0002-3016-9654
Zhang, Tianyi
Yin, Chenghong
Qiao, Jie http://orcid.org/0000-0003-2126-1376
Guo, Wei http://orcid.org/0000-0002-9937-7152
Funding for this research was provided by:
Ministry of Science and Technology of the People’s Republic of China (2017YFE0126500)
National Natural Science Foundation of China (81501105, 31730034)
Beijing Municipal Science and Technology Commission (Z151100003915118)
Article History
Received: 24 July 2020
Accepted: 12 January 2022
First Online: 17 February 2022
Competing interests
: B.L. and W.G. are co-inventors of the filed patents related to the TrkB agonistic antibodies. B.L. is also a co-founder and Scientific Advisor of 4B Technologies, Limited, a biotech company that develops medicines for neurodegenerative diseases. The remaining authors declare no competing interests.